CTHRC1 and neoplasm: In both models, treatment with the anti-CTHRC1 antibody resulted in a significant tumor growth suppression; the combination of gemcitabine and the anti-CTHRC1 antibody caused the most significant tumor suppression in the orthotopic model (Figure 7B,F and Figure S5 show tumor images).